The Patent Finder

Nutramax Laboratories, Inc.

Also on record
Records under this name other than the patents Nutramax Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.

Back to Nutramax Laboratories, Inc.

PatentTitleStatus Expires Confidence
US 8,808,770Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
Term ended
Term ended Apr 30, 2026 · From the USPTO record
Term endedTerm ended Apr 30, 2026From the USPTO record
US 9,572,791Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
Term ended
Term ended Apr 1, 2026 · From the USPTO record
Term endedTerm ended Apr 1, 2026From the USPTO record
US 10,456,372Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
Term ended
Ended no later than Jul 29, 2025 · From the USPTO record
Term endedEnded no later than Jul 29, 2025From the USPTO record
US 10,780,077Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
Term ended
Ended no later than Jul 29, 2025 · From the USPTO record
Term endedEnded no later than Jul 29, 2025From the USPTO record
US 11,419,848Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
Term ended
Ended no later than Jul 29, 2025 · From the USPTO record
Term endedEnded no later than Jul 29, 2025From the USPTO record
US 8,568,803Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
Term ended
Term ended Jul 19, 2021 · From the USPTO record
Term endedTerm ended Jul 19, 2021From the USPTO record
US 8,753,697Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
Term ended
Term ended Mar 6, 2021 · From the USPTO record
Term endedTerm ended Mar 6, 2021From the USPTO record
US 7,563,779L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
Term ended
Term ended Nov 16, 2020 · From the USPTO record
Term endedTerm ended Nov 16, 2020From the USPTO record
US 8,846,118Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
Term ended
Term ended Oct 19, 2020 · From the USPTO record
Term endedTerm ended Oct 19, 2020From the USPTO record
US 6,863,906L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
Term ended
Term ended Sep 25, 2019 · From the USPTO record
Term endedTerm ended Sep 25, 2019From the USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited